Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 Jul;126(1 Suppl):78S-92S
Date
07/14/2004Pubmed ID
15249497DOI
10.1378/chest.126.1_suppl.78SScopus ID
2-s2.0-3142777629 (requires institutional sign-in at Scopus site) 478 CitationsAbstract
Although idiopathic pulmonary arterial hypertension is perceived as a progressive disease with a uniformly poor outcome, the natural history of disease is heterogeneous, with some patients dying within months of diagnosis and others living for decades. The course of the disease has also been altered by advances in medical therapies. The outcome of patients with other types of pulmonary arterial hypertension (PAH) has been less well characterized. Assessment of prognosis of such patients is important, as it influences both medical therapy and referral for transplantation. This chapter will provide evidence based recommendations to assess the prognosis of patients with PAH.
Author List
McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G, American College of Chest PhysiciansAuthor
Kenneth W. Presberg MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
BiomarkersEchocardiography
Electrocardiography
Evidence-Based Medicine
Exercise Test
Humans
Hypertension, Pulmonary
Prognosis
Pulmonary Artery
Respiratory Function Tests
Risk Factors
